# Prepare a conference-season watchlist Canonical URL: https://biopharmsignal.com/use-cases/small-biotech-fund-teams/prepare-a-conference-season-watchlist Role: [Small Biotech Fund Teams](https://biopharmsignal.com/use-cases/small-biotech-fund-teams.md) Category: Catalysts and competitive evidence Last updated: 2026-07-26 Coordinate abstract, presentation, and post-conference monitoring. ## The Situation A major medical meeting is approaching and a small fund needs to prioritize abstracts, presentations, portfolio companies, and competitor programs. ### Best Fit Portfolio managers, analysts, associates, and operations leads at small healthcare and event-driven investment funds. ## The Challenge Coordinate abstract, presentation, and post-conference monitoring. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. ## How To Think About The Task A major medical meeting is approaching and a small fund needs to prioritize abstracts, presentations, portfolio companies, and competitor programs. For small fund teams, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again. Coordinate abstract, presentation, and post-conference monitoring. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later. ### Start with the decision this work must support “Prepare a conference-season watchlist” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful. ### Build a source-linked change record The core monitoring set for this workflow includes expected new versus encore data, portfolio and target relevance, abstract and presentation timing, prior data for comparison, analyst ownership during the meeting. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot. ### Turn monitoring into an owned output A conference watchlist with program, session, expected evidence, prior-data baseline, portfolio implication, and assigned analyst. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The team covers the presentations most likely to change a thesis while avoiding duplicate work across a high-volume meeting. ## Illustrative Example ### Illustrative workflow: prepare a conference-season watchlist Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change. Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event. ### Questions To Answer Before Making A Decision - What has changed in expected new versus encore data, and why does it matter? - What has changed in portfolio and target relevance, and why does it matter? - What has changed in abstract and presentation timing, and why does it matter? - What has changed in prior data for comparison, and why does it matter? - What has changed in analyst ownership during the meeting, and why does it matter? ## A Repeatable Workflow 1. Define the specific decision or research question behind “prepare a conference-season watchlist.” 2. Set the monitored scope around expected new versus encore data and portfolio and target relevance. 3. Collect source-linked updates for abstract and presentation timing and record what changed from the prior state. 4. Review prior data for comparison together with analyst ownership during the meeting before drawing a conclusion. 5. Produce the required output, assign follow-up ownership, and set the next review point. ## Signals To Keep Visible - Expected new versus encore data - Portfolio and target relevance - Abstract and presentation timing - Prior data for comparison - Analyst ownership during the meeting ## Common Mistakes - Starting the monitoring process without a defined decision question - Recording the latest state without preserving its source or previous state - Ending with collected information but no owner, conclusion, or next review ## Deliverable A conference watchlist with program, session, expected evidence, prior-data baseline, portfolio implication, and assigned analyst. ## Practical Outcome The team covers the presentations most likely to change a thesis while avoiding duplicate work across a high-volume meeting. ## Where BioPharmSignal Fits Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep relevant tickers and keywords visible. The workflow still requires independent research and judgment. ## Frequently Asked Questions ### Who is this workflow for? It is designed for small biotech fund teams and adjacent biotech research users who need a repeatable, source-linked way to complete this task. ### What should this workflow produce? A conference watchlist with program, session, expected evidence, prior-data baseline, portfolio implication, and assigned analyst. ### What is the practical benefit? The team covers the presentations most likely to change a thesis while avoiding duplicate work across a high-volume meeting. ## Related Workflows - [How a Small Biotech Fund Builds a Daily News Briefing](https://biopharmsignal.com/use-cases/small-biotech-fund-teams/daily-biotech-news-briefing.md) - [How Small Funds Maintain a Shared Biotech Catalyst Calendar](https://biopharmsignal.com/use-cases/small-biotech-fund-teams/shared-biotech-catalyst-calendar.md) - [How Small Funds Track Competitive Read-Throughs in Biotech](https://biopharmsignal.com/use-cases/small-biotech-fund-teams/competitive-read-throughs.md) Format note: This is an illustrative workflow guide, not a named customer testimonial or a claim of investment performance.